Abstract:Background: It is essential to consider a practical antibody test to successfully implement marker vaccines and validate vaccination efficacy against classical swine fever virus (CSFV). The test should include a serological antibody assay, combined with a tool for differentiating infected from vaccinated animals (DIVA). The immunochromatographic test strip (ICS) has been exclusively designed for detecting CSFV E2 antibodies while lacking in detecting E rns antibodies, which can be employed and satisfy DIVA strategy. This study developed a novel ICS for detecting CSFV E2/E rns dual-antibody. The effectiveness of ICS in evaluating the DIVA capability of two novel chimeric pestivirus vaccine candidates was assessed. Methods: Recombinant E2 or E rns protein was transiently expressed in the plant benthamiana using Agrobacterium tumefaciens . ICS was subsequently assembled, and goat anti-rabbit IgG and recombinant CSFV E2 or E rns protein were plated onto the nitrocellulose membrane as control and test lines, respectively. The sensitivity and specificity of ICS were evaluated using sera with different neutralizing antibody titers or positive for antibodies against CSFV and other pestiviruses. The coincidence rates for detecting E2 and E rns antibodies between ICS and commercial enzyme-linked immunosorbent assay (ELISA) kits were also computed. ICS performance for DIVA capability was evaluated using sera from pigs vaccinated with conventional vaccine or chimeric vaccine candidates. Results: E2 and E rns proteins were successfully expressed in N. benthamiana -produced recombinant proteins. ICS demonstrated high sensitivity in identifying CSFV E2 and E rns antibodies, even at the low neutralizing antibody titers. No cross-reactivity with antibodies from other pestiviruses was confirmed using ICS. There were high agreement rates of 93.0 and 96.5% between ICS and two commercial ELISA kits for E2 antibody testing. ICS also achieved strong coincidence rates of 92.9 and 89.3% with two ELISA kits for E rns antibody detection. ICS confirmed the absence of CSFV E rns -specific antibodies in sera from pigs vaccinated with chimeric vaccine candidates. Conclusion: E2 and E rns proteins derived from the plant showed great potential and can be used to engineer a CSFV E2/E rns dual-antibody ICS. The ICS was also highly sensitive and specific for detecting CSFV E2 and E rns antibodies. Significantly, ICS can fulfill the DIVA concept by incorporating chimeric vaccine candidates.

Epitope-Containing Short Peptides Capture Distinct IgG Serodynamics That Enable Differentiating Infected from Vaccinated Animals for Live-Attenuated Vaccines

Expression of the Major Epitope Regions of 2C Integrated with the 3AB Non-Structural Protein of Foot-and-mouth Disease Virus and Its Potential for Differentiating Infected from Vaccinated Animals

High-throughput Sequencing of the Porcine Antibody Repertoire with or Without PEDV Infection: A Proof-of-concept Study.

Virus-like particles: promising platforms with characteristics of DIVA for veterinary vaccine design.

Development and Application of an Indirect Enzyme-Linked Immunosorbent Assay Using Recombinant S1 for Serological Testing of Porcine Epidemic Diarrhea Virus

Safety, efficacy, and DIVA feasibility on a novel live attenuated classical swine fever marker vaccine candidate

Development Of A Blocking Elisa Based On A Monoclonal Antibody Against A Predominant Epitope In Non-Structural Protein 3b2 Of Foot-And-Mouth Disease Virus For Differentiating Infected From Vaccinated Animals

Enzyme Linked Immunosorbent Assays Based on Recombinant S1 and Its Truncated Proteins to Measure Porcine Serum IgA Antibody Against PEDV Could Reflect Neutralization Activity

Safety and DIVA Capability of Novel Live Attenuated Classical Swine Fever Marker Vaccine Candidates in Pregnant Sows

Deletion of the EP402R Gene from the Genome of African Swine Fever Vaccine Strain ASFV-G-∆I177L Provides the Potential Capability of Differentiating between Infected and Vaccinated Animals

Development of a dual immunochromatographic test strip to detect E2 and Erns antibodies against classical swine fever

A Novel Competitive ELISA for Specifically Measuring and Differentiating Immune Responses to Classical Swine Fever C-Strain Vaccine in Pigs

Development of an Indirect ELISA to Distinguish between Porcine Sapelovirus-Infected and -Vaccinated Animals Using the Viral Nonstructural Protein 3AB

Development and Validation of a New DIVA Real-Time PCR Allowing to Differentiate Wild-Type Lumpy Skin Disease Virus Strains, Including the Asian Recombinant Strains, from Neethling-Based Vaccine Strains

Development and Optimization of Indirect ELISAs for the Detection of Anti-Capripoxvirus Antibodies in Cattle, Sheep, and Goat Sera

Candidate Peptide-Vaccine Induced Potent Protection Against Csfv and Identified A Principal Sequential Neutralizing Determinant on E2

Development of a Blocking ELISA Using a Monoclonal Antibody to a Dominant Epitope in Non-Structural Protein 3A of Foot-and-Mouth Disease Virus, As a Matching Test for a Negative-Marker Vaccine

Development of a Synthesized Gene Unique to Lumpy Skin Disease Virus and Its Application in Serological Differentiation of Naturally Infected from Vaccinated Cattle with Attenuated Goat Pox Vaccine

Development of an indirect ELISA for the immunoprotection evaluation of E2 antibodies against classical swine fever virus

Candidate peptide-vaccines induced immunity against CSFV and identified sequential neutralizing determinants in antigenic domain A of glycoprotein E2.

Development of a Blocking Immunoperoxidase Monolayer Assay for Differentiation Between Pseudorabies Virus-Infected and Vaccinated Animalss